Enzoflam Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50mg, Paracetamol 325mg, and Serratiopeptidase 15mg. This formulation is indicated for the management of acute and chronic pain associated with musculoskeletal disorders, postoperative inflammation, rheumatoid arthritis, osteoarthritis, and other inflammatory conditions. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis responsible for pain and inflammation. Paracetamol provides analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, complementing the anti-inflammatory action of Diclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and swelling, enhancing tissue repair. The combined action of these agents results in effective pain relief, reduction of inflammation, and improved functional mobility. Enzoflam Tablet should be administered as directed by a healthcare professional, with caution advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. Monitoring for adverse effects such as gastrointestinal discomfort, allergic reactions, or altered liver function is recommended during therapy. This combination offers a comprehensive approach for managing pain and inflammation in various clinical scenarios.